These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31665089)

  • 1. Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases.
    Bernatz S; Ilina EI; Devraj K; Harter PN; Mueller K; Kleber S; Braun Y; Penski C; Renner C; Halder R; Jennewein L; Solbach C; Thorsen F; Pestalozzi BC; Mischo A; Mittelbronn M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):434. PubMed ID: 31665089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
    He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
    J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.
    Hamester F; Stürken C; Saygi C; Qi M; Legler K; Gorzelanny C; Robador JR; Schmalfeldt B; Laakmann E; Müller V; Witzel I; Oliveira-Ferrer L
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
    Duan S; Luo X; Zeng H; Zhan X; Yuan C
    Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
    Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
    Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy.
    Cui W; Zhao H; Wang C; Chen Y; Luo C; Zhang S; Sun B; He Z
    Drug Deliv; 2019 Dec; 26(1):542-550. PubMed ID: 31090467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.
    Nounou MI; Adkins CE; Rubinchik E; Terrell-Hall TB; Afroz M; Vitalis T; Gabathuler R; Tian MM; Lockman PR
    Pharm Res; 2016 Dec; 33(12):2930-2942. PubMed ID: 27528392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes Derived from Brain Metastatic Breast Cancer Cells Destroy the Blood-Brain Barrier by Carrying lncRNA GS1-600G8.5.
    Lu Y; Chen L; Li L; Cao Y
    Biomed Res Int; 2020; 2020():7461727. PubMed ID: 32337272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model.
    Logie J; Ganesh AN; Aman AM; Al-Awar RS; Shoichet MS
    Biomaterials; 2017 Apr; 123():39-47. PubMed ID: 28161682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.
    Fitzgerald DP; Emerson DL; Qian Y; Anwar T; Liewehr DJ; Steinberg SM; Silberman S; Palmieri D; Steeg PS
    Mol Cancer Ther; 2012 Sep; 11(9):1959-67. PubMed ID: 22622283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
    Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heading in a new direction: drug permeability in breast cancer brain metastasis.
    Sledge GW
    Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
    Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
    Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective permeabilization of the blood-brain barrier at sites of metastasis.
    Connell JJ; Chatain G; Cornelissen B; Vallis KA; Hamilton A; Seymour L; Anthony DC; Sibson NR
    J Natl Cancer Inst; 2013 Nov; 105(21):1634-43. PubMed ID: 24108809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prediction of response to docetaxel in breast cancer].
    Kim SJ; Noguchi S
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):190-3. PubMed ID: 18281755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. βIII-Tubulin Regulates Breast Cancer Metastases to the Brain.
    Kanojia D; Morshed RA; Zhang L; Miska JM; Qiao J; Kim JW; Pytel P; Balyasnikova IV; Lesniak MS; Ahmed AU
    Mol Cancer Ther; 2015 May; 14(5):1152-61. PubMed ID: 25724666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubulin Tyrosine Ligase Like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis.
    Arnold J; Schattschneider J; Blechner C; Krisp C; Schlüter H; Schweizer M; Nalaskowski M; Oliveira-Ferrer L; Windhorst S
    J Exp Clin Cancer Res; 2020 Sep; 39(1):205. PubMed ID: 32998758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-1-Dependent Destabilization of the Blood-Brain Barrier in Chronic Stroke.
    Sladojevic N; Stamatovic SM; Johnson AM; Choi J; Hu A; Dithmer S; Blasig IE; Keep RF; Andjelkovic AV
    J Neurosci; 2019 Jan; 39(4):743-757. PubMed ID: 30504279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.